<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1373</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>1994</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>8</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>AUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF MOPP AND ABVD-RESI STANT HODGKIN'S DISEASE</title>
	<subject_fa>Oncology</subject_fa>
	<subject>Oncology</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Six patients with disseminated Hodgkin's disease resistant to MOPP
(mechlorethamine, vincristine, procarbazine and prednisolone), and ABVD
(adriamycin, bleomycin, vinblastine and dacarbazine) chemotherapy were treated
with high-dose chemotherapy and autologous marrow transplantation. The patients
first underwent marrow aspiration and storage for subsequent autologous bone
marrow transplantation (AB MT).
Three patients remain alive in unmaintained complete remission (CR) at I X, 17,
and 15 months after transplant. In the other three patients, reasons for faiJure included
relapse in two patients after 7 and g months, and death after 6 months due to
pulmonary infection (pneumonia).
These results demonstrate that some patients with MOPP, ABVD and other
salvage chemotherapy (SC)-resistant Hodgkin's disease can obtain prolonged
complete remission following intensive chemotherapy and autologous marrow
transplantation
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Autologous marrow transplantation, Hodgkin\'s disease.</keyword>
	<start_page>9</start_page>
	<end_page>16</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-600&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>TALEB</first_name>
	<middle_name></middle_name>
	<last_name>AZARM</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846006087</code>
	<orcid>20031947532846006087</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Division of Hematology/Oncology and B.M.T., Seyyed-al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
